{"name": "Heptares Therapeutics",
 "permalink": "heptares-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/heptares-therapeutics",
 "homepage_url": "http://www.heptares.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@heptares.com",
 "phone_number": "44-(0)1707-358-628",
 "description": "Small Molecule Drug Discovery",
 "created_at": "Tue Oct 13 04:29:41 UTC 2009",
 "updated_at": "Tue Oct 13 20:40:52 UTC 2009",
 "overview": "\u003Cp\u003EHeptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.\u003C/p\u003E\n\n\u003Cp\u003EThe Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs\u00e2\u201e\u00a2, Stabilised Receptors), overcoming a major limiting factor to the development of new drugs targeting this group.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       19],
      "assets/images/resized/0006/2562/62562v1-max-150x150.jpg"],
     [[250,
       32],
      "assets/images/resized/0006/2562/62562v1-max-250x250.jpg"],
     [[379,
       49],
      "assets/images/resized/0006/2562/62562v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "BioPark, Broadwater Road",
    "address2": "Welwyn Garden City ",
    "zip_code": "AL7 3AX",
    "city": "Hertfordshire",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Hot Heptares inks $200M tech pact with Novartis\r\n",
    "stoned_year": 2009,
    "stoned_month": 10,
    "stoned_day": 12,
    "source_url": "http://www.fiercebiotech.com/story/hot-heptares-inks-200m-tech-pact-novartis/2009-10-12?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_text": "",
    "source_description": "Hot Heptares inks $200M tech pact with Novartis",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Heptares Therapeutics",
      "permalink": "heptares-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        124],
       "assets/images/resized/0006/2563/62563v1-max-150x150.jpg"],
      [[250,
        207],
       "assets/images/resized/0006/2563/62563v1-max-250x250.jpg"],
      [[450,
        372],
       "assets/images/resized/0006/2563/62563v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}